Home › Anxiety › NCT07672925

FlowMD Feasibility Study

Feasibility of Using a Meditation App in Adults With Anxiety Disorder

Who can join

Ages 18 to 65 · All sexes

Inclusion Criteria:

* Are 18-65 years old
* Have an anxiety disorder
* Have a smartphone
* Able to download the FlowMD app
* Willing to use the FlowMD meditation app for a daily 1-5 minute session for four consecutive weeks
* Able to provide feedback on the experience using the app
* Willing to participate in surveys to measure changes in anxiety levels

Exclusion Criteria:

* Are undergoing significant changes in psychiatric medication or therapy
* Have severe psychiatric conditions that might interfere with study participation (Schizophrenia, Bipolar Disorder, Major Depressive Disorder)

About the study

The goal of this clinical trial is to learn if the FlowMD mobile app is feasible to be used to manage mild anxiety in adults. It will also learn if the app is effective at managing anxiety in adults.

Participants will:

Use the FlowMD app daily to complete a 1-5 minute guided breathwork session over the course of 4 weeks.

Complete surveys at the beginning, midpoint, and end of the study to measure anxiety levels and usability of the app.

What is being tested

• Intervention (other)

Sponsor: National University of Natural Medicine · Participants: 40 · Started: Oct 15, 2025

Contact the study team

• Michelle T Berg, Master of Clinical Research · Phone: 1 503 552 1885

Official record on ClinicalTrials.gov — NCT07672925

Locations in the U.S.

Conditions

• Anxiety

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.